Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss
ConditionBlood Loss
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-90
SponsorMeir Medical Center
About this trial
Assessing the efficiency of Prophylactic use of local tranexamic acid during vaginal hysterectomy to reduce blood loss during operation
Eligibility criteria
This trial accepts healthy volunteersQualifiers
20-90 years old female patients going through vaginal hysterctomy
Disqualifiers
massive bleeding during operation due to major vessles injury
known coagulopathies
sensitivity to tranexamic acid
medical need in tranexamic acid administration during operation due to bleeding
Trial design
Design model
Single group
Treatments tested in this trial
local tranexamic acid injection
Druglocal tranexamic acid injection to cervix- 1 g tranexamic acid diluted in 10 ml saline
local normal saline injection to cervix
Other interventionlocal normal saline injection to the cervix- 20 ml saline
Treatment groups
60 Participants
are divided into 2 treatment groupsGroup A: local tranexamic acid injection to cervixExperimental treatment 1 intervention
Group B: local normal saline injection to cervixPlacebo comparator 1 intervention
Trial outcomes
Primary outcomes
1
Blood loss during operation - measure in ml
At the end of the surgery, surgeon will measure the blood in the suction can
Time frame
End of surgerySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov